Comparison of the efficacy of first-line combinations for metastatic clear cell renal cell carcinoma: A propensity score-matched analysis of Japanese multicenter database

被引：0
|
作者：
Yanagisawa, T. [1 ]
Mori, K. [1 ]
Fukuokaya, W. [1 ]
Kawada, T. [2 ]
Katayama, S. [2 ]
Uchimoto, T. [3 ]
Tsujino, T. [3 ]
Nishimura, K. [3 ]
Adachi, T. [4 ]
Toyoda, S. [5 ]
Komura, K. [3 ]
Takahara, K. [6 ]
Hashimoto, T. [4 ]
Fujita, K. [5 ]
Azuma, H. [3 ]
Ohno, Y. [4 ]
Shiroki, R. [6 ]
Uemura, H. [5 ]
Araki, M. [2 ]
Kimura, T. [1 ]
机构：
[1] Jikei Univ, Sch Med, Dept Urol, Tokyo, Japan
[2] Okayama Univ, Grad Sch Med, Dept Urol, Okayama, Japan
[3] Osaka Med & Pharmaceut Univ, Dept Urol, Osaka, Japan
[4] Tokyo Med Univ, Dept Urol, Tokyo, Japan
[5] Kindai Univ, Fac Med, Dept Urol, Osaka, Japan
[6] Fujita Hlth Univ, Sch Med, Dept Urol, Nagoya, Aichi, Japan
来源：
EUROPEAN UROLOGY | 2024年 / 85卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
A0836
引用
收藏
页码：S1856 / S1857
页数：2
相关论文
共 50 条
  • [31] First-line sunitinib versus pazopanib in metastatic renal cell carcinoma: Results from the International Metastatic Renal Cell Carcinoma Database Consortium
    Ruiz-Morales, Jose Manuel
    Swierkowski, Marcin
    Wells, J. Connor
    Fraccon, Anna Paola
    Pasini, Felice
    Donskov, Frede
    Bjarnason, Georg A.
    Lee, Jae-Lyun
    Sim, Hao-Wen
    Sliwczynsk, Andrzej
    Ptak-Chmielewska, Aneta
    Teter, Zbigniew
    Beuselinck, Benoit
    Wood, Lori A.
    Yuasa, Takeshi
    Pezaro, Carmel
    Rini, Brian I.
    Szczylik, Cezary
    Choueiri, Toni K.
    Heng, Daniel Y. C.
    EUROPEAN JOURNAL OF CANCER, 2016, 65 : 102 - 108
  • [32] Progression-free Survival After Second Line of Therapy for Metastatic Clear Cell Renal Cell Carcinoma in Patients Treated with First-line Immunotherapy Combinations
    Fitzgerald, Kelly N.
    Duzgol, Cihan
    Knezevic, Andrea
    Shapnik, Natalie
    Kotecha, Ritesh
    Aggen, David H.
    Carlo, Maria I.
    Shah, Neil J.
    Voss, Martin H.
    Feldman, Darren R.
    Motzer, Robert J.
    Lee, Chung -Han
    EUROPEAN UROLOGY, 2023, 83 (03) : 195 - 199
  • [33] New TKI/IO Combinations in the First-line Therapy of metastatic Renal Cell Carcinoma Comment
    Grabbert, Markus
    AKTUELLE UROLOGIE, 2022, 53 (01) : 18 - +
  • [34] First-Line Treatment of Metastatic Clear Cell Renal Cell Carcinoma: What Are the Most Appropriate Combination Therapies?
    Vano, Yann-Alexandre
    Ladoire, Sylvain
    Elaidi, Reza
    Dermeche, Slimane
    Eymard, Jean-Christophe
    Falkowski, Sabrina
    Gross-Goupil, Marine
    Malouf, Gabriel
    Narciso, Berangere
    Sajous, Christophe
    Tartas, Sophie
    Voog, Eric
    Ravaud, Alain
    CANCERS, 2021, 13 (21)
  • [35] Nomogram Predicting Prognosis in Metastatic Patients with Clear Cell Renal Cell Carcinoma Treated by First-Line Sunitinib
    Kammerer-Jacquet, Solene-Florence
    Dugay, Frederic
    Bensalah, Karim
    Brunot, Angelique
    Peyronnet, Benoit
    Mathieu, Romain
    Verhoest, Gregory
    Lefort, Mathilde
    Bayat, Sahar
    Lespagnol, Alexandra
    Mosser, Jean
    Edeline, Julien
    Laguerre, Brigitte
    Dupuis, Frantz
    Yacoub, Mokrane
    Ravaud, Alain
    Bernhard, Jean-Christophe
    Belaud-Rotureau, Marc-Antoine
    Rioux-Leclercq, Nathalie
    MODERN PATHOLOGY, 2017, 30 : 234A - 234A
  • [36] Nomogram Predicting Prognosis in Metastatic Patients with Clear Cell Renal Cell Carcinoma Treated by First-Line Sunitinib
    Kammerer-Jacquet, Solene-Florence
    Dugay, Frederic
    Bensalah, Karim
    Brunot, Angelique
    Peyronnet, Benoit
    Mathieu, Romain
    Verhoest, Gregory
    Lefort, Mathilde
    Bayat, Sahar
    Lespagnol, Alexandra
    Mosser, Jean
    Edeline, Julien
    Laguerre, Brigitte
    Dupuis, Frantz
    Yacoub, Mokrane
    Ravaud, Alain
    Bernhard, Jean-Christophe
    Belaud-Rotureau, Marc-Antoine
    Rioux-Leclercq, Nathalie
    LABORATORY INVESTIGATION, 2017, 97 : 234A - 234A
  • [37] Efficacy and safety of first-line sunitinib in Chinese patients with metastatic renal cell carcinoma
    Qin, Shu-Kui
    Jin, Jie
    Guo, Jun
    Wang, Jin-Wan
    Zhou, Fang-Dian
    Huang, Yi-Ran
    Ren, Xiu-Bao
    Ye, Ding-Wei
    Pan, Sharon
    Sajben, Peter
    Wang, Qiao
    FUTURE ONCOLOGY, 2018, 14 (18) : 1835 - 1845
  • [38] Sunitinib: the First to Arrive at First-Line Metastatic Renal Cell Carcinoma
    Vazquez, Sergio
    Leon, Luis
    Fernandez, Ovidio
    Lazaro, Martin
    Grande, Enrique
    Aparicio, Luis
    ADVANCES IN THERAPY, 2012, 29 (03) : 202 - 217
  • [39] Sunitinib: the First to Arrive at First-Line Metastatic Renal Cell Carcinoma
    Sergio Vázquez
    Luis León
    Ovidio Fernández
    Martín Lázaro
    Enrique Grande
    Luis Aparicio
    Advances in Therapy, 2012, 29 : 202 - 217
  • [40] Therapeutic sequencing in the era of first-line immune checkpoint inhibitor combinations, a novel challenge in patients with metastatic clear-cell renal cell carcinoma
    Flippot, Ronan
    Gorgeu, Violaine
    Pujalte, Marc
    Colomba, Emeline
    Alves, Carolina
    Cerbone, Luigi
    Carril, Lucia
    Derosa, Lisa
    Escudier, Bernard
    Albiges, Laurence
    BULLETIN DU CANCER, 2022, 109 (02) : S31 - S38
12345